Prognostic markers of post-stroke depression (PROMoSD): study protocol of a prospective single-center observational study on raphe hypoechogenicity as a predictor of post-stroke depression.

Daniel RichterAndreas EbertLisa Mazul-WachQuirin RulandJeyanthan Charles-JamesRalf GoldGeorgios TsivgoulisGeorg JuckelChristos Krogias

Published in: Neurological research and practice (2022)

The results of PROMoSD will answer the question of whether screening of BRH after AIS improves the prediction of PSD occurrence. A positive result of this study could have direct consequences on psychiatric support after AIS by streamlining diagnostic and therapeutic algorithms. Trial registration ClinicalTrials.gov identifier no. NCT05580198.

Keyphrases

study protocol
depressive symptoms
randomized controlled trial
clinical trial
sleep quality
machine learning
mental health
risk assessment
deep learning
phase iii
phase ii